| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Africa CDC campaigns for continental health autonomy
|
Adepoju, Paul
|
|
|
3 |
9 |
p. e650
|
article
|
| 2 |
A predominant genotype of azole-resistant Candida tropicalis clinical strains
|
Tseng, Kuo-Yun
|
|
|
3 |
9 |
p. e646
|
article
|
| 3 |
Assessment of the 2021 WHO Mycobacterium tuberculosis drug resistance mutation catalogue on an independent dataset
|
Hall, Michael B
|
|
|
3 |
9 |
p. e645
|
article
|
| 4 |
Correction to Lancet Microbe 2022; published online May 31. https://doi.org/10.1016/S2666-5247(22)00151-3
|
|
|
|
3 |
9 |
p. e649
|
article
|
| 5 |
Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis
|
Gao, Ya
|
|
|
3 |
9 |
p. e683-e692
|
article
|
| 6 |
Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions
|
Ulaeto, David O
|
|
|
3 |
9 |
p. e639-e640
|
article
|
| 7 |
Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study
|
Marijke Braet, Sofie
|
|
|
3 |
9 |
p. e693-e700
|
article
|
| 8 |
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study
|
Finci, Iris
|
|
|
3 |
9 |
p. e672-e682
|
article
|
| 9 |
Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
|
Karaba, Andrew H
|
|
|
3 |
9 |
p. e644
|
article
|
| 10 |
Monkeypox: it could have been different
|
The Lancet Microbe,
|
|
|
3 |
9 |
p. e638
|
article
|
| 11 |
New guidance for researching acute hepatitis in children
|
Venkatesan, Priya
|
|
|
3 |
9 |
p. e651
|
article
|
| 12 |
Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions
|
Magalhães, Luísa M D
|
|
|
3 |
9 |
p. e711-e722
|
article
|
| 13 |
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
|
Watson, Oliver J
|
|
|
3 |
9 |
p. e701-e710
|
article
|
| 14 |
Projected burden and duration of the 2022 Monkeypox outbreaks in non-endemic countries
|
Bisanzio, Donal
|
|
|
3 |
9 |
p. e643
|
article
|
| 15 |
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
|
Jenkin, Daniel
|
|
|
3 |
9 |
p. e663-e671
|
article
|
| 16 |
Threat from Mycobacterium orygis-associated tuberculosis in south Asia
|
Thapa, Jeewan
|
|
|
3 |
9 |
p. e641-e642
|
article
|
| 17 |
Threshold-free genomic cluster detection to track transmission pathways in health-care settings: a genomic epidemiology analysis
|
Hawken, Shawn E
|
|
|
3 |
9 |
p. e652-e662
|
article
|
| 18 |
We should not underestimate the role of biofilms in persistent (chronic) bronchitis
|
Everard, Mark Lloyd
|
|
|
3 |
9 |
p. e647
|
article
|
| 19 |
We should not underestimate the role of biofilms in persistent (chronic) bronchitis – Authors' reply
|
Marsh, Robyn L
|
|
|
3 |
9 |
p. e648
|
article
|
Journal description